Bell Potter Remains a Buy on Medical Developments International Limited (MVP)Tip Ranks·Aug 24 at 01:05 AM
MVP: Revenue up 9% and net profit after tax rose to $0.6M, driven by Pain Management growthQuartr·Aug 20 at 12:10 AM
Bell Potter Sticks to Its Buy Rating for Medical Developments International Limited (MVP)Tip Ranks·Jul 26 at 11:35 PM
MVP: Strong cashflow and Penthrox growth, with expanded paediatric approval in Europe and UKQuartr·Jul 23 at 11:49 PM
Medical Developments International Lifts Cash Flow on Strong Penthrox DemandTip Ranks·Apr 23 at 11:15 PM
Medical Developments International Delivers Positive Cashflow as Penthrox Growth Offsets Respiratory SoftnessTip Ranks·Jan 29 at 10:42 PM
